Biotechnology in rheumatology and immunology for researchers: An overview
Biotechnology has revolutionized the fields of rheumatology and immunology, providing innovative solutions for understanding and treating autoimmune diseases. Traditionally, these fields relied on basic immunological techniques and limited therapeutic options. However, advancements in biotechnology...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Amaltea Medical Publishing House
2024-06-01
|
| Series: | Romanian Journal of Rheumatology |
| Subjects: | |
| Online Access: | https://rjr.com.ro/articles/2024.2/RJR_2024_2_Art-05.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Biotechnology has revolutionized the fields of rheumatology and immunology, providing innovative solutions for understanding and treating autoimmune diseases. Traditionally, these fields relied on basic immunological techniques
and limited therapeutic options. However, advancements in biotechnology have introduced novel diagnostic tools, targeted therapies, and personalized medicine approaches, significantly improving patient outcomes. The aim of this
overview is to provide researchers with a comprehensive understanding of the current biotechnological advancements in rheumatology and immunology, highlighting their impact on disease diagnosis, management, and treatment. The primary objective is to explore the various biotechnological innovations that have transformed rheumatology and immunology. This includes the development of biologics, biomarkers, and genetic tools that have enabled precise diagnosis and tailored treatments. Additionally, the overview seeks to examine the ongoing research and future directions in these fields, emphasizing the potential for further breakthroughs. Biotechnology has significantly advanced the fields of rheumatology and immunology, offering new hope for patients with autoimmune diseases. The introduction of biologics has been a game-changer, allowing for targeted therapies that have improved disease management and patient quality of life. Biomarker discovery has enhanced diagnostic accuracy and enabled the monitoring of disease progression. Genetic
and genomic tools have paved the way for personalized medicine, tailoring treatments to individual patient profiles. As research continues to evolve, the integration of biotechnology in these fields promises to bring even more innovative solutions, ultimately transforming the landscape of autoimmune disease treatment and management. Researchers must stay abreast of these developments to continue driving progress and improving patient outcomes. |
|---|---|
| ISSN: | 1843-0791 2069-6086 |